T. Rowe Price Associates’s eHealth EHTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95K Buy
73,336
+15,600
+27% +$36.2K ﹤0.01% 3011
2025
Q4
$266K Buy
57,736
+14,800
+34% +$65.2K ﹤0.01% 2702
2025
Q3
$186K Hold
42,936
﹤0.01% 2812
2025
Q2
$187K Buy
42,936
+14,036
+49% +$70.4K ﹤0.01% 2737
2025
Q1
$194K Buy
28,900
+9,500
+49% +$86.4K ﹤0.01% 2655
2024
Q4
$183K Hold
19,400
﹤0.01% 2717
2024
Q3
$80K Sell
19,400
-2,323
-11% -$10K ﹤0.01% 2862
2024
Q2
$99K Sell
21,723
-7,571
-26% -$38.1K ﹤0.01% 2761
2024
Q1
$177K Buy
29,294
+817
+3% +$5.42K ﹤0.01% 2655
2023
Q4
$249K Buy
28,477
+269
+1% +$2.2K ﹤0.01% 2452
2023
Q3
$209K Buy
28,208
+1,381
+5% +$10.8K ﹤0.01% 2488
2023
Q2
$216K Sell
26,827
-2,800
-9% -$22.4K ﹤0.01% 2498
2023
Q1
$278K Buy
29,627
+4,047
+16% +$31.8K ﹤0.01% 2385
2022
Q4
$124K Buy
25,580
+676
+3% +$2.52K ﹤0.01% 2671
2022
Q3
$98K Buy
24,904
+4,569
+22% +$31.9K ﹤0.01% 2733
2022
Q2
$190K Sell
20,335
-4,491
-18% -$45.7K ﹤0.01% 2616
2022
Q1
$308K Sell
24,826
-146,389
-86% -$2.52M ﹤0.01% 2539
2021
Q4
$4.37M Sell
171,215
-28,125
-14% -$934K ﹤0.01% 1511
2021
Q3
$8.07M Sell
199,340
-34,050
-15% -$1.59M ﹤0.01% 1448
2021
Q2
$13.6M Buy
233,390
+16,281
+7% +$1.07M ﹤0.01% 1373
2021
Q1
$15.8M Sell
217,109
-139,320
-39% -$8.91M ﹤0.01% 1328
2020
Q4
$25.2M Buy
356,429
+69,392
+24% +$5.27M ﹤0.01% 1163
2020
Q3
$22.7M Buy
287,037
+273,620
+2,039% +$22.2M ﹤0.01% 1118
2020
Q2
$1.32M Buy
13,417
+724
+6% +$84.2K ﹤0.01% 1672
2020
Q1
$1.79M Sell
12,693
-58,331
-82% -$6.69M ﹤0.01% 1529
2019
Q4
$6.82M Sell
71,024
-39,148
-36% -$3.04M ﹤0.01% 1360
2019
Q3
$7.36M Buy
110,172
+683
+0.6% +$61.6K ﹤0.01% 1330
2019
Q2
$9.43M Buy
109,489
+34,652
+46% +$2.33M ﹤0.01% 1321
2019
Q1
$4.67M Buy
74,837
+65,884
+736% +$3.63M ﹤0.01% 1412
2018
Q4
$344K Buy
8,953
+50
+0.6% +$1.68K ﹤0.01% 2232
2018
Q3
$252K Buy
+8,903
New +$236K ﹤0.01% 2407
2017
Q4
Sell
-8,844
Closed -$211K 2575
2017
Q3
$211K Buy
+8,844
New +$180K ﹤0.01% 2395
2015
Q1
Sell
-8,800
Closed -$219K 2549
2014
Q4
$219K Hold
8,800
﹤0.01% 2318
2014
Q3
$212K Hold
8,800
﹤0.01% 2310
2014
Q2
$334K Hold
8,800
﹤0.01% 2129
2014
Q1
$447K Sell
8,800
-1,042,100
-99% -$54.3M ﹤0.01% 1964
2013
Q4
$48.9M Sell
1,050,900
-4,500
-0.4% -$188K 0.01% 845
2013
Q3
$34M Sell
1,055,400
-56,900
-5% -$1.57M 0.01% 944
2013
Q2
$25.3M Buy
+1,112,300
New +$25M 0.01% 1006

Other funds holding EHTH

T. Rowe Price Associates's EHTH Position: Q1 2026 in Review

T. Rowe Price Associates increased its eHealth (EHTH) stake by 27% in Q1 2026, buying an estimated $36.2K and bringing the position to 73,336 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #3011.

T. Rowe Price Associates first reported a position in EHTH in Q2 2013 and has held it in 39 quarters since. The position peaked at $48.9M in Q4 2013. 104 funds tracked by Wall St. Rank hold EHTH as of Q1 2026.

  • T. Rowe Price Associates held 73,336 shares of eHealth worth $95K as of Q1 2026.
  • T. Rowe Price Associates bought 15,600 eHealth shares in Q1 2026, an estimated $36.2K.
  • eHealth made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #3011 holding.
  • T. Rowe Price Associates first reported a position in eHealth in Q2 2013 and has held it in 39 quarters since.
  • T. Rowe Price Associates's eHealth position peaked at $48.9M in Q4 2013.
  • 104 funds tracked by Wall St. Rank held eHealth as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.